Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO).
Methods
This was an unmasked post hoc analysis of the randomized HAWK/HARRIER clinical trials. Patients with neovascular AMD in the brolucizumab...
Alternative Titles
Full title
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9061681
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9061681
Other Identifiers
ISSN
0721-832X
E-ISSN
1435-702X
DOI
10.1007/s00417-021-05518-0
